tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Bausch + Lomb Ends Agreement with Icahn Group

Story Highlights
  • Bausch + Lomb ended its agreement with Carl Icahn’s group after their stake fell below a required threshold.
  • Brett Icahn and Gary Hu resigned from the board, with no disagreements cited with the company.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Bausch + Lomb Ends Agreement with Icahn Group

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Bausch + Lomb Corporation ( (BLCO) ) is now available.

On August 14, 2025, Bausch + Lomb Corporation announced the termination of the Amended and Restated Director Appointment and Nomination Agreement with Carl C. Icahn and his affiliates, following the Icahn Group’s reduced stake in Bausch Health Companies Inc. Consequently, Brett Icahn and Gary Hu resigned from the company’s board of directors. The resignations were not due to any disagreements with the company, and Bausch + Lomb’s CEO expressed gratitude for their contributions over the past three years.

The most recent analyst rating on (BLCO) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock Forecast page.

Spark’s Take on BLCO Stock

According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.

Bausch + Lomb Corporation’s overall stock score reflects a balance of positive growth prospects and significant profitability challenges. The raised financial guidance and strong performance in key segments are encouraging, but ongoing losses and cash flow issues weigh heavily. Technical indicators provide some support, but valuation concerns persist due to negative earnings.

To see Spark’s full report on BLCO stock, click here.

More about Bausch + Lomb Corporation

Bausch + Lomb is a global leader in eye health, offering a comprehensive portfolio of approximately 400 products, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. Founded in 1853, the company has a significant global presence with around 13,500 employees and operations in approximately 100 countries. Headquartered in Vaughan, Ontario, Bausch + Lomb is dedicated to enhancing vision for people worldwide.

Average Trading Volume: 807,514

Technical Sentiment Signal: Hold

Current Market Cap: $5.15B

Find detailed analytics on BLCO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1